PANCREATIC CA

Clinical trials for PANCREATIC CA explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC CA trials appear

Sign up with your email to follow new studies for PANCREATIC CA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Immune cells supercharged to fight cancer: early trial shows promise

Disease control Completed

This early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…

Matched conditions: PANCREATIC CA

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

PANCREATIC CA

Get alerted when new PANCREATIC CA trials appear

Immune cells supercharged to fight cancer: early trial shows promise